Back to Search Start Over

Recovery From COVID-19-Related Olfactory Disorders and Quality of Life: Insights From an Observational Online Study

Authors :
Christophe A. H. Bousquet
Aurélien Kassan
Lesly Fornoni
Moustafa Bensafi
Catherine Rouby
Pierre-Emmanuel Aguera
Erwan Moussy
Christelle Daudé
Marylou Mantel
Arnaud Fournel
Morgane Dantec
Maëlle Moranges
Camille Ferdenzi
Stéphane Richard Ortegón
Centre de recherche en neurosciences de Lyon (CRNL)
Université Claude Bernard Lyon 1 (UCBL)
Université de Lyon-Université de Lyon-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Centre de recherche en neurosciences de Lyon - Lyon Neuroscience Research Center (CRNL)
Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Ferdenzi, Camille
Source :
Chemical Senses, Chemical Senses, Oxford University Press (OUP), 2021, 46, ⟨10.1093/chemse/bjab028⟩, Chemical Senses, 2021, 46, pp.bjab028. ⟨10.1093/chemse/bjab028⟩
Publication Year :
2021
Publisher :
HAL CCSD, 2021.

Abstract

Although olfactory disorders (OD) are among the most significant symptoms of COVID-19, recovery time from COVID-19-related OD and their consequences on the quality of life remain poorly documented. We investigated the characteristics and behavioral consequences of COVID-19-related OD using a large-scale study involving 3111 French respondents (78% women) to an online questionnaire over a period of 9 months covering different epidemic waves (from 8 April 2020 to 13 January 2021). In the patients who subjectively recovered from COVID-19-related OD (N = 609), recovery occurred on average after 16 days and most of the time within 1 month (“normal” recovery range); 49 subjectively recovered in 1–2.5 months, and several cases took up to 6.5 months. Among the patients with ongoing OD (N = 2502), 974 were outside the “normal” recovery range (persistent OD) and reported OD for 1–10 months. Developing a persistent OD was more likely with increasing age and in women and was more often associated with parosmia and phantosmia. The deleterious impact of COVID-19-related OD on the quality of life was significantly aggravated by OD duration and was more pronounced in women. Because persistent OD is not infrequent after COVID-19, has deleterious consequences on the quality of life, and receives few solutions from the health practitioners, it would be beneficial to implement screening and treatment programs to minimize the long-term behavioral consequences of COVID-19-related OD.

Details

Language :
English
ISSN :
0379864X and 14643553
Database :
OpenAIRE
Journal :
Chemical Senses, Chemical Senses, Oxford University Press (OUP), 2021, 46, ⟨10.1093/chemse/bjab028⟩, Chemical Senses, 2021, 46, pp.bjab028. ⟨10.1093/chemse/bjab028⟩
Accession number :
edsair.doi.dedup.....e33a0e987f744e22ab502389863ba890